OPS
CPRX icon

Orion Portfolio Solutions’s Catalyst Pharmaceutical CPRX Stock Holding History

Orion Portfolio Solutions’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$262K Buy
+10,820
New +$244K ﹤0.01% 1685
2024
Q4 		– Sell
-13,212
Closed -$263K – 1838
2024
Q3 		$263K Sell
13,212
-80
-0.6% -$1.48K ﹤0.01% 1588
2024
Q2 		$206K Sell
13,292
-190
-1% -$2.96K ﹤0.01% 1630
2024
Q1 		$215K Buy
13,482
+3,199
+31% +$48.2K ﹤0.01% 1587
2023
Q4 		$155K Sell
10,283
-2,645
-20% -$36.2K ﹤0.01% 1603
2023
Q3 		$151K Sell
12,928
-886
-6% -$11.9K ﹤0.01% 1571
2023
Q2 		$186K Buy
13,814
+3,155
+30% +$45.4K ﹤0.01% 1563
2023
Q1 		$177K Buy
+10,659
New +$176K ﹤0.01% 1506

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return